Abstract:BACKGROUND:As a result of extensive use of fluroquinlones and cephalosporins, urinary tract pathogens producing extended-spectrum beta-lactamase (ESBL) pose a considerable clinical challenge in the treatment of UTIs. In the present study we retrospectively assessed the susceptibility of E. coli strains to fosfomycin trometamol and other antibiotics commonly used for the treatment of such infections.METHODS:A total of 908 nonreplicate clinical E. coli urinary isolates were collected from 20 Chinese hospitals over four consecutive 1-year periods between October 2004 and June 2012. Susceptibility to antimicrobial agents fosfomycin trometamol, piperacillin-tazobactam, cefuroxime, cefotaxime, cefepime, imipenem, amikacin, levofloxacin, and nitrofurantoin was determined using the agar dilution method. A reference strain E. coli (ATCC 25922) was used as a positive control. Results were analyzed using Chi-square test or Fisher's exact tests.RESULTS:Fosfomycin trometamol, piperacillin-tazobactam, amikacin, and imipenem were consistently the most active agents against most of the isolates. There was a decline in susceptibility to cefuroxime, cefotaxime, and cefepime between 2004 and 2010. We showed that 528 of the 908 E. coli isolates (58.1%) produced ESBLs. The ESBL-positive rates increased from 41.7% in 2004-2005 to 60.9% in 2011-2012. ESBL-producing E. coli isolates showed significantly higher resistance rates to levofloxacin than the ESBL-negative isolates. Fosfomycin trometamol, piperacillin-tazobactam, amikacin, and imipenem had good activity against both levofloxacin-susceptible and levofloxacin- nonsusceptible isolates (sensitivity rate > 90%). However susceptibility of levofloxacin-resistant isolates to cefuroxime, cefotaxime, cefepime, amikacin, and nitrofurantoin was significantly lower than that of levofloxacin-susceptible isolates.CONCLUSIONS:Owing to the increase in the bacterial resistance across the world, the European Urology Association has recommended fosfomycin trometamol as the drug of choice in its Guidelines on Urological Infections released in 2013. Our results confirm this recommendation for use in China and continued monitoring of the susceptibility of E. coli to fosfomycin trometamol is need with the widely use of the drug in China.

Randomized-controlled Clinical Trial on Fosfomycin Trometamal Versus Ciprofloxacin in the Treatment of Urological Tract Bacterial Infections

Efficacy and Safety of Oral Fosfomycin Trometamol for the Treatment of Lower Urinary Tract Infections Caused by Multi Drug Resistant Bacteria：an Open-Label, Uncontrolled, Multicenter Study

Multicenter Randomized Controlled Clinical Trial on Teicoplanin Versus Vancomycin

Efficacy and safety of fosfomycin trometamol for urinary tract infection: a Meta-analysis

Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study.

EFFICACY AND SAFETY OF ORAL FOSFOMYCIN TROMETAMOL POWDER FOR THE TREATMENT OF URINARY TRACT INFECTIONS CAUSED BY INDWELLING BLADDER CATHETER

Randomized controlled study on sparfloxacin and minocycline in treatment of male nongonococcal urethritis

Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis

Evaluation of perioperative prophylaxis with fosfomycin tromethamine in ureteroscopic stone removal: an investigator-driven prospective, multicenter, randomized, controlled study

A Double-Blind, Randomized Controlled Clinical Study:Gatifloxacin Vs Levofloxacin in Treatment of 98 Patients with Urinary Tract Infections

A randomized comparative study of gatifloxacin and ciprofloxacin in the treatment of bacterial infections

A Randomized Controlled Clinical Study on Levofloxacin Versus Ciprofloxacin in the Treatment of Bacterial Infections

Letter to the Editor for the Article “antibiotics Efficacy in Clinical and Microbiological Cure of Uncomplicated Urinary Tract Infection: a Systematic Review and Network Meta-Analysis”

Efficacy and Safety of Moxifloxacin for the Treatment of Genitourinary Tract Infection with Drug Resistance Mycoplasma

A Randomized, Patient-Blind, Multicenter Comparison of Gatifloxacin Versus Levofloxacin in the Treatment of Lower Respiratory Tract Infections and Urinary Tract Infections

Randomized Controlled Multicentric Clinical Trial of Domestic and Imported Cefepime in the Treatment of Acute Urinary Infections

In Vitro Susceptibility of Escherichia Coli Strains Isolated from Urine Samples Obtained in Mainland China to Fosfomycin Trometamol and Other Antibiotics: a 9-Year Surveillance Study (2004–2012)

Effect of mercifloxacin and levofloxacin on urinary tract infection

A Multiple Center Randomized Controlled Clinical Study of Pazufloxacin Mesylate for Injection in Treatment of Patients with Acute Bacterial Infections

Safety and Efficacy of Levofloxacin Versus Ciprofloxacin for the Treatment of Chronic Bacterial Prostatitis in Chinese Patients

Bacteriological Efficacy of Gatifloxacin Methanesulfonate Tablet on Acute Bacterial Infections